BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

878 related articles for article (PubMed ID: 20003098)

  • 1. Characterization of sleep-wake patterns in a novel transgenic mouse line overexpressing human prepro-orexin/hypocretin.
    Mäkelä KA; Wigren HK; Zant JC; Sakurai T; Alhonen L; Kostin A; Porkka-Heiskanen T; Herzig KH
    Acta Physiol (Oxf); 2010 Mar; 198(3):237-49. PubMed ID: 20003098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuronal activity of orexin and non-orexin waking-active neurons during wake-sleep states in the mouse.
    Takahashi K; Lin JS; Sakai K
    Neuroscience; 2008 May; 153(3):860-70. PubMed ID: 18424001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prepro-hypocretin (prepro-orexin) expression is unaffected by short-term sleep deprivation in rats and mice.
    Terao A; Peyron C; Ding J; Wurts SW; Edgar DM; Heller HC; Kilduff TS
    Sleep; 2000 Nov; 23(7):867-74. PubMed ID: 11083595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Orexins: from neuropeptides to energy homeostasis and sleep/wake regulation.
    Beuckmann CT; Yanagisawa M
    J Mol Med (Berl); 2002 Jun; 80(6):329-42. PubMed ID: 12072908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brain orexins and wake regulation in rats exposed to maternal deprivation.
    Feng P; Vurbic D; Wu Z; Strohl KP
    Brain Res; 2007 Jun; 1154():163-72. PubMed ID: 17466285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Orexin neuronal circuitry: role in the regulation of sleep and wakefulness.
    Ohno K; Sakurai T
    Front Neuroendocrinol; 2008 Jan; 29(1):70-87. PubMed ID: 17910982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modafinil more effectively induces wakefulness in orexin-null mice than in wild-type littermates.
    Willie JT; Renthal W; Chemelli RM; Miller MS; Scammell TE; Yanagisawa M; Sinton CM
    Neuroscience; 2005; 130(4):983-95. PubMed ID: 15652995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective stimulation of orexin receptor type 2 promotes wakefulness in freely behaving rats.
    Akanmu MA; Honda K
    Brain Res; 2005 Jun; 1048(1-2):138-45. PubMed ID: 15919057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Opposite effects of sleep rebound on orexin OX1 and OX2 receptor expression in rat brain.
    D'Almeida V; Hipólide DC; Raymond R; Barlow KB; Parkes JH; Pedrazzoli M; Tufik S; Nobrega JN
    Brain Res Mol Brain Res; 2005 May; 136(1-2):148-57. PubMed ID: 15893599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Narcolepsy and the hypocretins.
    Wurtman RJ
    Metabolism; 2006 Oct; 55(10 Suppl 2):S36-9. PubMed ID: 16979425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Symptomatic narcolepsy, cataplexy and hypersomnia, and their implications in the hypothalamic hypocretin/orexin system.
    Nishino S; Kanbayashi T
    Sleep Med Rev; 2005 Aug; 9(4):269-310. PubMed ID: 16006155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Roles of orexin/hypocretin in regulation of sleep/wakefulness and energy homeostasis.
    Sakurai T
    Sleep Med Rev; 2005 Aug; 9(4):231-41. PubMed ID: 15961331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paradoxical (REM) sleep deprivation in mice using the small-platforms-over-water method: polysomnographic analyses and melanin-concentrating hormone and hypocretin/orexin neuronal activation before, during and after deprivation.
    Arthaud S; Varin C; Gay N; Libourel PA; Chauveau F; Fort P; Luppi PH; Peyron C
    J Sleep Res; 2015 Jun; 24(3):309-19. PubMed ID: 25524602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Orexins and orexin receptors: from molecules to integrative physiology.
    Matsuki T; Sakurai T
    Results Probl Cell Differ; 2008; 46():27-55. PubMed ID: 18204827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypothalamus, hypocretins/orexin, and vigilance control.
    Nishino S
    Handb Clin Neurol; 2011; 99():765-82. PubMed ID: 21056227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between the activation of MCH and orexin immunorective neurons and REM sleep architecture during REM rebound after a three day long REM deprivation.
    Kitka T; Adori C; Katai Z; Vas S; Molnar E; Papp RS; Toth ZE; Bagdy G
    Neurochem Int; 2011 Oct; 59(5):686-94. PubMed ID: 21740944
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypocretins (orexins): clinical impact of the discovery of a neurotransmitter.
    Baumann CR; Bassetti CL
    Sleep Med Rev; 2005 Aug; 9(4):253-68. PubMed ID: 15979356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Participation of histaminergic H1 and noradrenergic alpha 1 receptors in orexin A-induced wakefulness in rats.
    Shigemoto Y; Fujii Y; Shinomiya K; Kamei C
    Brain Res; 2004 Oct; 1023(1):121-5. PubMed ID: 15364026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microdialysis perfusion of orexin-A in the basal forebrain increases wakefulness in freely behaving rats.
    Thakkar MM; Ramesh V; Strecker RE; McCarley RW
    Arch Ital Biol; 2001 Apr; 139(3):313-28. PubMed ID: 11330208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Roles of the hypocretin/orexins in the regulation of sleep and wakefulness.
    Terao A; Haruyama T; Kimura K
    Jpn J Vet Res; 2008 Jan; 55(2-3):75-83. PubMed ID: 18318109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 44.